{"AllianceGenome": "5474", "HGNC": "5474", "MIM": "146734", "_id": "3488", "_version": 1, "accession": {"genomic": ["AC007563.2", "AH003147.2", "AY534685.1", "CH471063.1", "CP068276.2", "CS138154.1", "JA139569.1", "JA139576.1", "JA139685.1", "JA139692.1", "NC_000002.12", "NC_060926.1", "U20271.1"], "protein": ["AAA53505.1", "AAA72051.1", "AAC09368.1", "AAD04730.1", "AAH08099.1", "AAH11453.1", "AAH18427.1", "AAS16353.1", "AAV38512.1", "AAV38513.1", "AAY14662.1", "BAG37488.1", "CAG33090.1", "CAJ21553.1", "CCA64016.1", "CCA64017.1", "CCA64018.1", "CCA64019.1", "EAW70574.1", "EAW70575.1", "NP_000590.1", "P24593.1"], "rna": ["AF055033.1", "AF147308.1", "AK314992.1", "AU132181.1", "AV710460.1", "BC008099.1", "BC011453.1", "BC018427.1", "BC032366.1", "BC039838.1", "BC046102.1", "BC073984.1", "BC089383.1", "BE795293.1", "BM920595.1", "BQ717583.1", "BQ940805.1", "BT019706.1", "BT019707.1", "CD679409.1", "CR456809.1", "DA691367.1", "L27560.1", "M62782.1", "M65062.1", "NM_000599.4", "R71383.1"], "translation": [{"protein": "BAG37488.1", "rna": "AK314992.1"}, {"protein": "AAH11453.1", "rna": "BC011453.1"}, {"protein": "AAC09368.1", "rna": "AF055033.1"}, {"protein": "AAH18427.1", "rna": "BC018427.1"}, {"protein": "CAG33090.1", "rna": "CR456809.1"}, {"protein": "NP_000590.1", "rna": "NM_000599.4"}, {"protein": "AAD04730.1", "rna": "M65062.1"}, {"protein": "AAV38512.1", "rna": "BT019706.1"}, {"protein": "AAA53505.1", "rna": "M62782.1"}, {"protein": "AAV38513.1", "rna": "BT019707.1"}, {"protein": "AAH08099.1", "rna": "BC008099.1"}]}, "alias": "IBP5", "ensembl": {"gene": "ENSG00000115461", "protein": ["ENSP00000233813", "ENSP00000413474"], "transcript": ["ENST00000233813", "ENST00000449583", "ENST00000486341"], "translation": [{"protein": "ENSP00000233813", "rna": "ENST00000233813"}, {"protein": "ENSP00000413474", "rna": "ENST00000449583"}], "type_of_gene": "protein_coding"}, "entrezgene": "3488", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 6.16656226501, "exp_mis": 115.710487283, "exp_syn": 52.2413341536, "lof_z": 2.45986483483297, "mis_z": 1.98754011999449, "mu_lof": 5.02845603796e-07, "mu_mis": 1.26417440073e-05, "mu_syn": 6.09011846802e-06, "n_lof": 0.0, "n_mis": 72.0, "n_syn": 41.0, "p_li": 0.859978350463281, "p_null": 0.0021354650065906, "p_rec": 0.137886184530129, "syn_z": 0.964184253386918}, "bp": 819, "cds_end": 217559498, "cds_start": 217541473, "n_exons": 4, "nonpsych": {"exp_lof": 5.5079943718, "exp_mis": 104.655820248, "exp_syn": 47.2101073243, "lof_z": 2.30488202410982, "mis_z": 1.90587649542006, "mu_lof": 5.02845603796e-07, "mu_mis": 1.26417440073e-05, "mu_syn": 6.09011846802e-06, "n_lof": 0.0, "n_mis": 66.0, "n_syn": 32.0, "p_li": 0.845269253626402, "p_null": 0.00335111920667289, "p_rec": 0.151379627166925, "syn_z": 1.39372898498424}, "nontcga": {"exp_lof": 5.66608877688, "exp_mis": 106.446507279, "exp_syn": 48.0548790072, "lof_z": 2.34813436966847, "mis_z": 2.09796851388752, "mu_lof": 5.02845603796e-07, "mu_mis": 1.26417440073e-05, "mu_syn": 6.09011846802e-06, "n_lof": 0.0, "n_mis": 63.0, "n_syn": 36.0, "p_li": 0.840930210210498, "p_null": 0.00297705024838915, "p_rec": 0.156092739541113, "syn_z": 1.10107378609384}, "transcript": "ENST00000233813.4"}, "exons": [{"cdsend": 216694775, "cdsstart": 216676750, "chr": "2", "position": [[216672104, 216676882], [216678111, 216678231], [216678849, 216679079], [216694438, 216695549]], "strand": -1, "transcript": "NM_000599", "txend": 216695549, "txstart": 216672104}], "exons_hg19": [{"cdsend": 217559498, "cdsstart": 217541473, "chr": "2", "position": [[217536827, 217541605], [217542834, 217542954], [217543572, 217543802], [217559161, 217560272]], "strand": -1, "transcript": "NM_000599", "txend": 217560272, "txstart": 217536827}], "generif": [{"pubmed": 11821401, "text": "Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2)."}, {"pubmed": 11923300, "text": "role in stimulating growth and IGF-I secretion in intestinal smooth muscle by ras-dependent activation of MAP kinase signaling pathways"}, {"pubmed": 11973331, "text": "c-Myb and B-Myb transactivate the IGFBP-5 promoter through binding-dependent and -independent mechanisms."}, {"pubmed": 12005306, "text": "cDNA probes were used to analyze the gene expression of IGFBP-5 in luteinized granulosa cells from different-sized follicles after ovarian hyperstimulation. Transcript levels increased with increasing follicular fluid (FF) volume"}, {"pubmed": 12777377, "text": "IGFBP-5 is a potent growth inhibitor and proapoptotic agent in human breast cancer cells via modulation of cell cycle regulation and apoptotic mediators"}, {"pubmed": 14645245, "text": "Fibronectin and IGFBP-5 bind to each other, and this binding negatively regulates the ligand-dependent action of IGFBP-5 by triggering IGFBP-5 proteolysis."}, {"pubmed": 15001525, "text": "The IGFBP-5 C-domain is necessary and sufficient for its nuclear localization, and residues K206, K208, K217, and K218 are particularly critical. The IGFBP-5 N-domain contains a putative transactivation domain."}, {"pubmed": 15140223, "text": "IGF-II:VN and IGF-I:IGFBP-5:VN complexes may be useful in situations where enhanced keratinocyte cell migration and proliferation is required, such as in wound healing and skin regeneration."}, {"pubmed": 15155755, "text": "exogenous IGFBP-5 increases apoptosis by binding to and inhibiting the activities of insulin-like growth factors"}, {"pubmed": 15534875, "text": "Understanding the mechanism of how cleavage of IGFBP-5 by this protease (IGFBPase) alters its activity will help to further our understanding of the biologic actions of the IGFs"}, {"pubmed": 15618969, "text": "Inhibition of expression of IGFBP-5 by micro and small interfering RNA has marked effect on neuroblastoma cell proliferation, apoptosis, and differentiation"}, {"pubmed": 15650232, "text": "IGFBP-5 has a role in growth and differentiation of neuroblastoma cells"}, {"pubmed": 15661050, "text": "The expression of certain IGFBP is significantly altered in renal cell carcinoma"}, {"pubmed": 15681824, "text": "Insulin-like growth factor binding proteins 3 and 5 are xpressed in idiopathic pulmonary fibrosis and have a role in extracellular matrix deposition"}, {"pubmed": 15777798, "text": "Activation by C/EBP alpha and beta did not depend on their binding to the C/EBP site, since they still activated IGFBP-5 promoter."}, {"pubmed": 15780948, "text": "In that IGFBP-5 is thought to stimulate transgenic bone formation, directly or via the action of insulin-like growth factor 1, such changes in bone IGFBP-5 may be important to ensure robust bone acquisition in the early postnatal period."}, {"pubmed": 15802501, "text": "IGFBP-5 expression may influence extrinsic apoptotic pathways via a differential modulation of downstream cell survival and cell death pathways."}, {"pubmed": 15930103, "text": "Igfbp5-mediated fibroblast growth factor receptor 2-IIIb signals regulate the genetic program that controls the structure of the hair shaft medulla in transgenic mice."}, {"pubmed": 16007340, "text": "IGFBP-5 interacts with RASSF1C"}, {"pubmed": 16195401, "text": "Importance of the kinetics of association/dissociation in determining the enhancing or inhibiting effects of IGFBP-5 and the ability to generate an IGFBP-5 mutant with exclusively IGF-enhancing activity."}, {"pubmed": 16311053, "text": "In conclusion, our findings are consistent with the hypothesis that FHL-2 and ADAM-9 are important modulators of IGFBP-5 actions and are, in part, regulated in a coordinated manner in bone"}, {"pubmed": 16543235, "text": "there are several conserved residues in the IGFBP-5 N-terminal region that are critical for transactivation and IGFBP-2 and -3 also have strong transactivation activity in their N-domains"}, {"pubmed": 16716263, "text": "IGF-I and -II are chemotactic factors for mesenchymal progenitor cells; IGFBP-5 both modulates the IGF-I effect and directly stimulates migration of human mesenchymal progenitor cells"}, {"pubmed": 16865675, "text": "overexpression of IGFBP-5 may play a significant role in the malignant transformation of normal pancreatic epithelial cells"}, {"pubmed": 17067554, "text": "Inhibition of endogenously produced IGFBP-5 is associated with Bim-dependent apoptosis in NB cells."}, {"pubmed": 17071587, "text": "Overexpression of IGFBP-5 in mouse lung results in fibroblast activation, increased extracellular matrix deposition, and myofibroblastic changes."}, {"pubmed": 17242174, "text": "Promoter contains a CACCC-rich consensus sequence required for activation by MN1."}, {"pubmed": 17290407, "text": "study shows that down-regulation of IGFBP-5 protein correlates with cervical carcinogenesis and does so at a preneoplastic stage"}, {"pubmed": 17312271, "text": "Ratios between the IGFBPs and IGF(insulin-like growth factor), different IGFBPs, sequential proteolytic cleavage of IGFBPs, and association of activating proteinases are elements in the regulation of IGF receptor stimulation."}, {"pubmed": 17316888, "text": "A cDNA library consisting of 220 upregulated genes in tumour tissue was established and named as LSCC. Differential expression was confirmed in five of these genes, including IGFBP5, SQLE, RAP2B, CLDN1, and TBL1XR1."}, {"pubmed": 17496250, "text": "Phosphorylation and O-glycosylation both affected IGFBP-5 binding to heparin but not insulin-like growth factor binding or ternary complex formation with the acid-labile subunit."}, {"pubmed": 17595320, "text": "IGFBP-5 can interact with VDR to prevent RXR:VDR heterodimerization; IGFBP-5 may attenuate the 1,25(OH)2D3-induced expression of bone differentiation markers."}, {"pubmed": 17651454, "text": "Overexpression of IGFBP5 was associated with breast cancer"}, {"pubmed": 17804819, "text": "IGFBP-5 plays a role in the regulation of cellular senescence via a p53-dependent pathway and in aging-associated vascular diseases"}, {"pubmed": 17823924, "text": "Androgen suppressive therapy increases IGFBP5 in the bone marrow microenvironment and thereby may facilitate the progression of prostate cancer."}, {"pubmed": 17892529, "text": "Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus"}, {"pubmed": 18085517, "text": "This suggests that IGFBP-5 possesses an IGF-independent suppressor function"}, {"pubmed": 18161051, "text": "IGFBP-5 inducible by gankyrin overexpression may be involved human hepatocarcinogenesis."}, {"pubmed": 18210156, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18210156, "text": "Single nucleotide polymorphisms in IGFBP5 is associated with breast cancer"}, {"pubmed": 18311789, "text": "There is a novel function of ADAM-12m in chondrocyte proliferation and cloning in osteoarthritic cartilage through enhanced bioavailability of IGF-1 from the IGF-1-IGFBP-5 complex by selective IGFBP-5 digestion."}, {"pubmed": 18373644, "text": "IGFBP2 and IGFBP5 play a role in the development of metastasis and may serve as useful markers to predict lymph node metastasis in patients with small (T1) invasive breast carcinomas."}, {"pubmed": 18602100, "text": "A new approach for designing protein delivery systems using IGFBP-3/5 derived peptides based on the molecular mechanisms of IGF-independent activities of IGFBPs."}, {"pubmed": 18624948, "text": "Expression in gingival epithelial cells is associated with anti-apoptosis, migration and differentiation"}, {"pubmed": 18665784, "text": "patients with poor diabetes control have lower levels of IGF-1, and greater IGFBP-1, IGFBP-5, and bone-specific alkaline phosphatase"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18710598, "text": "IGFBP-5 plays an important role in the biology of breast cancer, especially in breast cancer metastasis [review]"}, {"pubmed": 18762576, "text": "IGFBP-5 promotes muscle cell differentiation by binding to and switching on the IGF-II auto-regulation loop."}, {"pubmed": 18775916, "text": "IGFBP-5 expression prevented tumor growth and inhibited tumor vascularity in a xenograft model of human ovarian cancer. These results are the first evidence showing that IGFBP-5 plays a role as tumor suppressor by inhibiting angiogenesis"}, {"pubmed": 18805800, "text": "mRNA levels of IGFBP5, a specific substrate for PAPP-A2 protease activity, were also significantly increased, suggesting a potential role for IGFBP5 in fetal and placental growth suppression during pre-eclampsia."}, {"pubmed": 18809517, "text": "Results suggest that NFI proteins are important regulators of IGFBP5 expression in human osteoblasts and thus in modulating IGFBP5 functions in bone."}, {"pubmed": 18957933, "text": "IGFBP5 has a gender-specific association with adiponectin, which may modulate the development of metabolic syndrome"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19250630, "text": "PSA secreted by prostate cancer cells degrades IGFBP-5 and augments the IGF signal transduction."}, {"pubmed": 19341485, "text": "Findings imply that the mutant form of IGFBP5 increases proliferation and motility of breast cancer cells and that mutation of the NLS in IGFBP5 results in localization of IGFBP5 in the cytoplasm."}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19476635, "text": "Increased IGFBP-5 is associated with cervical intraepithelial neoplasia and cervical carcinoma."}, {"pubmed": 19610136, "text": "These results indicate that IGFBP-5 expression affects the cell cycle and survival signal pathways and thus it may be an important mediator of pancreatic cancer cell growth."}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19628764, "text": "IGFBP-5 induces a fibrotic phenotype via the activation of MAPK signaling and the induction of nuclear Egr-1 that interacts with IGFBP-5 and promotes fibrotic gene transcription."}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19808657, "text": "Insulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of Galphai3."}, {"pubmed": 19843326, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19877176, "text": "OBSL1 modulates the expression of IGFBP2 and IGFBP5 proteins in 3-M syndrome."}, {"pubmed": 19948051, "text": "Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes."}, {"pubmed": 19950226, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20345844, "text": "Decreased Cav-1 expression in fibrotic diseases likely leads to increased deposition of IGFBP-5 in the extracellular matrix."}, {"pubmed": 20354179, "text": "insulin-like growth factor binding protein 5 is a modulator of tamoxifen resistance in breast cancer"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20416304, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20468064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20508032, "text": "Data indicate that retinal astrocytes enhance the proliferation of cone-like retinoblastoma cells by deploying IGFBP5, a factor that also provides trophic support to the tumor cells' non-neoplastic counterparts."}, {"pubmed": 20583135, "text": "Data show that IGFBP5 expression is down-regulated during 4HPR-induced neuronal differentiation of human RPE cells through a MAPK signal transduction pathway involving C/EBPbeta."}, {"pubmed": 20628624, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20634197, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20810604, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20819778, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20944648, "text": "IGFBP-5 has an effect on human hair shape."}, {"pubmed": 20949447, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20949447, "text": "The IGFBP5 polymorphism is functional and may potentially be a biomarker for susceptibility to late-stage risk of squamous cell carcinoma of the head and neck."}, {"pubmed": 21029365, "text": "Data revealed a strong induction of several genes encoding components of the extracellular matrix, such as collagens, COMP, IGFBP5 and biglycan."}, {"pubmed": 21191810, "text": "results suggest that PGE(2) may play an important role in controlling cellular senescence of HDFs through the regulation of IGFBP5 and therefore may contribute to inflammatory disorders associated with aging"}, {"pubmed": 21256825, "text": "the L-domain of IGFBP-5 is a novel TNFR1 ligand that functions as a competitive TNF-alpha inhibitor."}, {"pubmed": 21460855, "text": "Insulin-like growth factor binding protein 5 is a novel marker that has an important role in the pathogenesis of osteosarcoma. The loss of insulin-like growth factor binding protein 5 function may contribute to metastasis in osteosarcoma."}, {"pubmed": 21852217, "text": "We genotyped single-nucleotide polymorphisms of IGF1, IGF2, IGF1R, IGF2R, IGFBP1, IGFBP3, IGFBP5, IRS1, IRS2, and IRS in pancreatic cancer patients"}, {"pubmed": 22246875, "text": "This study demonistrated that IGFBP5 was significantly decreased in skeletal muscel in patient with amyotrophic lateral sclerosis."}, {"pubmed": 22252554, "text": "c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling"}, {"pubmed": 22328518, "text": "The IGFBP5 enhanced adhesion, it inhibited cell migration, although this was not evident using the truncated C-terminal mutant, suggesting that effects of IGFBP5 on adhesion and migration involve different mechanisms."}, {"pubmed": 22571677, "text": "VEGF may play a regulator role in human ovarian physiology by modulating the expression of IGF-II and IGFBP-5 in luteinized granulosa cells."}, {"pubmed": 23499909, "text": "IGFBP-5 modulates the efficiency of estrogen-triggered activation of the Akt/PKB signaling pathway which has been associated with growth factor/ ERalpha cross-talks."}, {"pubmed": 23539739, "text": "IGFBP-5 overexpression is a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder."}, {"pubmed": 23576565, "text": "Data suggest that insulin-like growth factor-binding protein 5 (IGFBP5) regulation by calcium-dependent chloride channel DOG1."}, {"pubmed": 23665505, "text": "IGFBP5 domains modulate tumorigenicity and metastasis of human osteosarcoma in different ways"}, {"pubmed": 24120850, "text": "IGFBP-5 is important in maintaining epithelial-mesenchymal boundaries and thus may limit metastasis and fibrosis by inducing an orderly repair mechanism, very distinct from the fibrotic disruption induced by TGFbeta1."}, {"pubmed": 24379630, "text": "Serum IGFBP-5 concentrations were lower in Crohn's disease patients compared to healthy controls regardless of disease activity or the presence of stricture formation."}, {"pubmed": 24551065, "text": "IGFBP-5 induces its pro-fibrotic effects, at least in part, via DOK5. IGFBP-5 and DOK5 are both increased in systemic sclerosis fibroblasts and tissues and may thus be acting in concert to promote fibrosis."}, {"pubmed": 25007054, "text": "IGFBP-5 may be a negative modulator of RASSF1C/ PIWIL1 growth-promoting activities."}, {"pubmed": 25248036, "text": "rs4442975 at 2q35 flanks a transcriptional enhancer that physically interacts with the promoter of IGFBP5. Evidence suggests that the g-allele confers increased breast cancer susceptibility through relative downregulation of IGFBP5."}, {"pubmed": 25422220, "text": "IGFBP5 mRNA expression is a good indicator in clinical outcome of breast cancer patients."}, {"pubmed": 25475528, "text": "Data indicate co-localization of insulin-like growth factor binding proteins IGFBP-4, IGFBP-5 in the syncytiotrophoblast layer of first trimester placental villi as early as 5 weeks of gestational age."}, {"pubmed": 25548030, "text": "Our results suggest that rs6214 on the IGF1 gene and rs2854744 near the IGFBP3 gene potentially play an important role with ASMI in Taiwanese older adults in a metropolitan area."}, {"pubmed": 25603050, "text": "miR-204-5p suppresses IGFBP5 expression by direct binding to the 3' untranslated region."}, {"pubmed": 25827480, "text": "Demethylation of IGFBP5 by Histone Demethylase KDM6B Promotes Mesenchymal Stem Cell-Mediated Periodontal Tissue Regeneration by Enhancing Osteogenic Differentiation and Anti-Inflammation Potentials."}, {"pubmed": 26010068, "text": "Results shed light on the mechanism of IGFBP5 as a potential tumor-suppressor in melanoma progression."}, {"pubmed": 26103640, "text": "data provide further insights into the role of cellular compartmentalization in IGFBP-5-induced fibrosis"}, {"pubmed": 26762731, "text": "Data demonstrate that dysregulation of miR-143-3p:Igfbp5 interactions in satellite cells with age may be responsible for age-related changes in satellite cell function."}, {"pubmed": 27050076, "text": "Co-ordinated and reciprocal alteration in IGFBP-2 and -5 expression may play a role in the acquisition of endocrine resistance in breast cancer."}, {"pubmed": 27484838, "text": "IGFBP5 promoted osteogenic differentiation potentials of periodontal ligament stem cells and Wharton's jelly umbilical cord stem cells via the JNK and MEK/Erk signalling pathways."}, {"pubmed": 27612043, "text": "IGFBP5 promoter and exon-I methylation did not have any differences between tumor and adjacent tissues so that IGFBP5 methylation did not change IGFBP5 gene regulation in breast cancer."}, {"pubmed": 27752126, "text": "Factor Xa induced endothelial cell senescence through IGFBP-5."}, {"pubmed": 28008951, "text": "These results suggest that the C-terminus of IGFBP-5 exerts anti-cancer activity by inhibiting angiogenesis via regulation of the Akt/ERK and NF-kB-VEGF/MMP-9 signaling pathway."}, {"pubmed": 28049695, "text": "dysregulation of DNMT3A and IGFBP5 is relevant to preeclampsia. Thus, we propose that DNMT3A and IGFBP5 can serve as potential markers and targets for the clinical diagnosis and therapy of preeclampsia."}, {"pubmed": 28554590, "text": "AMP-IBP5 markedly enhanced keratinocyte migration and proliferation. AMP-IBP5-induced keratinocyte activation was mediated by Mrg X1-X4 receptors with MAPK and NF-kappaB pathways."}, {"pubmed": 28835592, "text": "Data suggest that IGFBP5 nuclear import is mediated by KPNA5/KPNB1 complex; nuclear localization sequence of IGFBP5 is critical domain in this nuclear translocation. (IGFBP5 = insulin-like growth factor binding protein-5; KPNA5 = karyopherin subunit alpha-5; KPNB1 = karyopherin subunit beta-1/importin-beta)"}, {"pubmed": 29016699, "text": "MiR-137 inhibited cell proliferation and migration of vascular smooth muscle cells via targeting IGFBP-5 and modulating the mTOR/STAT3 signaling."}, {"pubmed": 29896299, "text": "The study exemplifies flow-dependent epigenetic regulation of endothelial gene expression, and also suggests that targeting the EZH2/H3K27me3/IGFBP5 pathway may offer novel therapeutics for inflammatory disorders such as atherosclerosis."}, {"pubmed": 30542696, "text": "Study results demonstrated that miR-885 promoted metastasis of colorectal cancer (CRC) in vitro, and that von Willebrand factor (vWF) and IGFBP5 are potential novel target genes of miR-885, indicating that the miR-885/vWF and miR-885/IGFBP5 axes may serve roles in the metastasis of CRC."}, {"pubmed": 30745575, "text": "PKNOX2 is a tumor suppressor in gastric cancer by activation of IGFBP5 and p53 signaling pathways"}, {"pubmed": 30810066, "text": "In vitro analyses revealed that ROS production was induced by recombinant and adenoviral vector-mediated IGFBP-5 (AdBP5) in a dose- and time-dependent manner, regulated through MEK/ERK and JNK signaling, and primarily mediated by NADPH oxidase (Nox). Silencing IGFBP-5 in systemic sclerosis and idiopathic pulmonary fibrosis fibroblasts reduced ROS production."}, {"pubmed": 31210318, "text": "MicroRNA-193a-3p participates in the progression of rheumatoid arthritis by regulating proliferation and apoptosis of MH7A cells through targeting IGFBP5."}, {"pubmed": 31290273, "text": "Down-regulation of insulin-like growth factor binding protein 5 is involved in intervertebral disc degeneration via the ERK signalling pathway."}, {"pubmed": 31401027, "text": "Birth weight and length Z-scores were negatively associated with Z-scores of intact IGFBP-4, PAPP-A, and PAPP-A2 levels"}, {"pubmed": 31404102, "text": "These data lend support for the idea that unidentified cortical proteins like IGFBP5, which may not manifest a known pathologic footprint, may contribute to motor and cognitive function in older adults."}, {"pubmed": 31886201, "text": "IGFBP5 is down regulated in Kidney renal papillary renal cell carcinoma kidney tissues compared to its expression in control tissues and that the expression of IGFBP5 is negatively related to patient survival"}, {"pubmed": 32194505, "text": "Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease."}, {"pubmed": 32484228, "text": "Protein QTL analysis of IGF-I and its binding proteins provides insights into growth biology."}, {"pubmed": 32585242, "text": "IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease."}, {"pubmed": 33010605, "text": "MiR-193b inhibits autophagy and apoptosis by targeting IGFBP5 in high glucose-induced trophoblasts."}, {"pubmed": 33035436, "text": "Homocysteine downregulates cardiac homeobox transcription factor NKX2.5 via IGFBP5."}, {"pubmed": 33823868, "text": "Single cell RNA sequencing identifies IGFBP5 and QKI as ciliated epithelial cell genes associated with severe COPD."}, {"pubmed": 34146516, "text": "Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element."}, {"pubmed": 34362467, "text": "LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis."}, {"pubmed": 34655977, "text": "LncRNA HOXA11-AS aggravates the keloid formation by targeting miR-148b-3p/IGFBP5 axis."}, {"pubmed": 34822133, "text": "Overexpression of long noncoding RNA MCM3AP-AS1 promotes osteogenic differentiation of dental pulp stem cells via miR-143-3p/IGFBP5 axis."}, {"pubmed": 34830489, "text": "Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5."}, {"pubmed": 35151245, "text": "Insulin-Like Growth Factor Binding Protein 5: an Important Regulator of Early Osteogenic Differentiation of hMSCs."}, {"pubmed": 35513854, "text": "Insulin-like growth factor 5 associates with human Ass plaques and promotes cognitive impairment."}, {"pubmed": 36680137, "text": "HLA-A, HSPA5, IGFBP5 and PSMA2 Are Restriction Factors for Zika Virus Growth in Astrocytic Cells."}, {"pubmed": 36918335, "text": "Circ_0008450 regulates keloid-derived fibroblast proliferation, migration, invasion and apoptosis with increased IGFBP5 through sponging miR-1224-5p."}, {"pubmed": 36949068, "text": "IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis."}, {"pubmed": 38159363, "text": "Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia."}, {"pubmed": 38318192, "text": "Transcriptional profile of human thymus reveals IGFBP5 is correlated with age-related thymic involution."}, {"pubmed": 38351010, "text": "IGFBP5 is released by senescent cells and is internalized by healthy cells, promoting their senescence through interaction with retinoic receptors."}, {"pubmed": 38874707, "text": "Mir-204-5p alleviates mitochondrial dysfunction by targeting IGFBP5 in diabetic cataract."}, {"pubmed": 38886900, "text": "Deletion of endothelial IGFBP5 protects against ischaemic hindlimb injury by promoting angiogenesis."}], "genomic_pos": {"chr": "2", "end": 216695549, "ensemblgene": "ENSG00000115461", "start": 216672105, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 217560248, "start": 217536828, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001558", "qualifier": "involved_in", "term": "regulation of cell growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001649", "qualifier": "involved_in", "term": "osteoblast differentiation"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 7525452, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007565", "qualifier": "involved_in", "term": "female pregnancy"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0014912", "pubmed": 10766744, "qualifier": "involved_in", "term": "negative regulation of smooth muscle cell migration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0017148", "pubmed": 15700281, "qualifier": "involved_in", "term": "negative regulation of translation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030336", "pubmed": 15700281, "qualifier": "involved_in", "term": "negative regulation of cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0031069", "qualifier": "involved_in", "term": "hair follicle morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035556", "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042593", "qualifier": "involved_in", "term": "glucose homeostasis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043567", "qualifier": "involved_in", "term": "regulation of insulin-like growth factor receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043568", "qualifier": "involved_in", "term": "positive regulation of insulin-like growth factor receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043569", "pubmed": 10766744, "qualifier": "involved_in", "term": "negative regulation of insulin-like growth factor receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0044342", "qualifier": "involved_in", "term": "type B pancreatic cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045668", "qualifier": "involved_in", "term": "negative regulation of osteoblast differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045926", "qualifier": "involved_in", "term": "negative regulation of growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048009", "qualifier": "involved_in", "term": "insulin-like growth factor receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048286", "qualifier": "involved_in", "term": "lung alveolus development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0048662", "pubmed": 10766744, "qualifier": "involved_in", "term": "negative regulation of smooth muscle cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051146", "qualifier": "involved_in", "term": "striated muscle cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051897", "qualifier": "involved_in", "term": "positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060056", "qualifier": "involved_in", "term": "mammary gland involution"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060416", "qualifier": "involved_in", "term": "response to growth hormone"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071320", "pubmed": 7559606, "qualifier": "involved_in", "term": "cellular response to cAMP"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071407", "pubmed": 7559606, "qualifier": "involved_in", "term": "cellular response to organic cyclic compound"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1901862", "qualifier": "involved_in", "term": "negative regulation of muscle tissue development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904205", "qualifier": "involved_in", "term": "negative regulation of skeletal muscle hypertrophy"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1904707", "pubmed": 29016699, "qualifier": "involved_in", "term": "positive regulation of vascular associated smooth muscle cell proliferation"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1904754", "pubmed": 29016699, "qualifier": "involved_in", "term": "positive regulation of vascular associated smooth muscle cell migration"}], "CC": [{"evidence": "NAS", "gocategory": "CC", "id": "GO:0005576", "pubmed": 14718574, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005788", "qualifier": "located_in", "term": "endoplasmic reticulum lumen"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0016942", "pubmed": 10766744, "qualifier": "part_of", "term": "insulin-like growth factor binding protein complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0042567", "pubmed": 9497324, "qualifier": "part_of", "term": "insulin-like growth factor ternary complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0001968", "qualifier": "enables", "term": "fibronectin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [15700281, 25910212, 31515488, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0031994", "qualifier": "enables", "term": "insulin-like growth factor I binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0031994", "pubmed": 10766744, "qualifier": "enables", "term": "insulin-like growth factor I binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0031995", "qualifier": "enables", "term": "insulin-like growth factor II binding"}]}, "homologene": {"genes": [[7955, 403039], [7955, 795084], [8364, 548796], [9031, 424220], [9544, 696339], [9598, 740317], [9606, 3488], [9615, 610316], [9913, 404185], [10090, 16011], [10116, 25285]], "id": 56489}, "interpro": [{"desc": "Insulin-like growth factor-binding protein, IGFBP", "id": "IPR000867", "short_desc": "IGFBP-like"}, {"desc": "Growth factor receptor cysteine-rich domain superfamily", "id": "IPR009030", "short_desc": "Growth_fac_rcpt_cys_sf"}, {"desc": "Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site", "id": "IPR017891", "short_desc": "Insulin_GF-bd_Cys-rich_CS"}, {"desc": "Insulin-like growth factor-binding protein family 1-6, chordata", "id": "IPR022321", "short_desc": "IGFBP_1-6_chordata"}, {"desc": "Thyroglobulin type-1", "id": "IPR000716", "short_desc": "Thyroglobulin_1"}, {"desc": "Insulin-like growth factor binding protein 5", "id": "IPR012213", "short_desc": "IGFBP-5"}, {"desc": "Thyroglobulin type-1 superfamily", "id": "IPR036857", "short_desc": "Thyroglobulin_1_sf"}], "ipi": ["IPI00029236", "IPI00924537"], "map_location": "2q35", "name": "insulin like growth factor binding protein 5", "other_names": ["IBP-5", "IGF-binding protein 5", "IGFBP-5", "insulin-like growth factor-binding protein 5"], "pantherdb": {"HGNC": "5474", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "96440", "ortholog_type": "LDO", "panther_family": "PTHR11551", "taxid": 10090, "uniprot_kb": "Q07079"}, {"RGD": "2876", "ortholog_type": "LDO", "panther_family": "PTHR11551", "taxid": 10116, "uniprot_kb": "P24594"}, {"Ensembl": "ENSGALG00000011468", "ortholog_type": "LDO", "panther_family": "PTHR11551", "taxid": 9031, "uniprot_kb": "F1ND88"}, {"ZFIN": "ZDB-GENE-070620-8", "ortholog_type": "O", "panther_family": "PTHR11551", "taxid": 7955, "uniprot_kb": "A0A2R8QF69"}, {"ZFIN": "ZDB-GENE-040319-2", "ortholog_type": "LDO", "panther_family": "PTHR11551", "taxid": 7955, "uniprot_kb": "B0S525"}], "uniprot_kb": "P24593"}, "pathway": {"reactome": [{"id": "R-HSA-381426", "name": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-8957275", "name": "Post-translational protein phosphorylation"}], "wikipathways": [{"id": "WP2877", "name": "Vitamin D Receptor Pathway"}, {"id": "WP289", "name": "Myometrial relaxation and contraction pathways"}, {"id": "WP3850", "name": "Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling"}, {"id": "WP615", "name": "Senescence and Autophagy in Cancer"}]}, "pdb": ["1BOE", "1H59", "7UFG"], "pfam": ["PF00086", "PF00219"], "pharmgkb": "PA29707", "pharos": {"target_id": 8145, "tdl": "Tchem"}, "pir": "A53748", "prosite": ["PS51162", "PS51323"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF251243", "relationship": "is"}, {"id": "GNF251244", "relationship": "is"}, {"id": "GNF251245", "relationship": "is"}, {"id": "GNF251246", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161293", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF032947", "relationship": "similar to"}, {"id": "GNF040254", "relationship": "similar to"}, {"id": "GNF041828", "relationship": "is"}, {"id": "GNF042762", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF006967", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF233560", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF336178", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF100431", "relationship": "is"}, {"id": "GNF140086", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1"], "protein": "NP_000590.1", "rna": "NM_000599.4", "translation": {"protein": "NP_000590.1", "rna": "NM_000599.4"}}, "reporter": {"HG-U133_Plus_2": ["1555997_s_at", "203424_s_at", "203425_s_at", "203426_s_at", "211958_at", "211959_at"], "HG-U95Av2": ["1396_at", "1601_s_at", "1677_at", "1678_g_at", "38650_at", "41420_at"], "HTA-2_0": "TC02002758.hg.1", "HuEx-1_0": ["2527268", "2598828"], "HuGene-1_1": "8058857", "HuGene-2_1": "16908197"}, "summary": "Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "IGFBP5", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334096"}, "unigene": "Hs.607212", "uniprot": {"Swiss-Prot": "P24593", "TrEMBL": "C9JXX4"}, "wikipedia": {"url_stub": "IGFBP5"}}